InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Madden Martin J., 董事. Officer active across 1 company, notably NovoCure Ltd. In total, 4 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €19k. Activity tracked since 9 June 2021. The latest transaction was disclosed on 3 June 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Martin J. Madden is a Board Member at NovoCure Ltd. He has a strong background in corporate governance and strategic development. Martin contributes to guiding board decisions and implementing best practices within the company.